Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ramachandra Rao Sangana
Observed name:
Ramachandra Sangana
Institution:
Andhra University
Observed institutions:
Andhra University,
Novartis (India),
Glenmark Pharmaceuticals (India),
Novartis Institutes for BioMedical Research,
Piramal (India)
ORCID:
0000-0003-3772-0370
Observed ORCID:
0000-0003-3772-0370
OpenAlex ID:
A5068494062
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
2017
·
Ramachandra Sangana
, Helen Gu
, et al.
·
Drug Metabolism and Disposition
·
39
PDF
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson’s disease model
2012
·
Abhisek Banerjee
, Sandip Patil
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
38
Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity
2022
·
Susanne Glowienke
, Ulrich Onken
, et al.
·
Regulatory Toxicology and Pharmacology
·
30
Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors
2013
·
Abhisek Banerjee
, Lakshminarayana Narayana
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation
2012
·
Abhisek Banerjee
, Pravin S. Yadav
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
24
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study
2024
·
Ramachandra Sangana
, Bernhards Ogutu
, et al.
·
The Journal of Clinical Pharmacology
·
16
PDF
Physiologically Based Biopharmaceutics Model of Vildagliptin Modified Release (MR) Tablets to Predict In Vivo Performance and Establish Clinically Relevant Dissolution Specifications
2022
·
Muzaffaruddin Ahmed Madny
, Pandurang Deshpande
, et al.
·
AAPS PharmSciTech
·
16
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer
2014
·
Venkatasubbaiah A Venkatesha
, Asavari Joshi
, et al.
·
Molecular Cancer
·
14
PDF
Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study
2022
·
Ramachandra Sangana
, Hemant Mittal
, et al.
·
Diabetes & Metabolic Syndrome Clinical Research & Reviews
·
10
Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers
2024
·
Ramachandra Sangana
, Yan Xu
, et al.
·
Clinical Pharmacology in Drug Development
·
7
The Bioequivalence Between Valsartan Oral Solution and Suspension Formulations Developed for Pediatric Use
2022
·
Rama Sivasubramanian
, Gangadhar Sunkara
, et al.
·
Clinical Pharmacology in Drug Development
·
2
Evaluation of metabolism and cytochrome P450 mediated interaction liabilities of naringenin
2023
·
Mallik Samarla
, Ramachandra Rao Sangana
·
Pre-Clinical Research
·
1
PDF
Optimization and Validation of Glycerol-induced Acute Renal Failure Model in Rats in Predicting the Pharmacokinetics in Patients with Acute Renal Failure
2022
·
Ramachandra Rao Sangana
·
Pharmacy and Drug Development
·
1
PDF
Pharmacokinetics of ganaplacide and lumefantrine in a pediatric population with Plasmodium falciparum uncomplicated malaria, treated with ganaplacide plus lumefantrine solid dispersion formulation: analysis of data from KALUMI, a multinational Phase 2 study
2026
·
Ramachandra Sangana
, Bakary Fofana
, et al.
·
Research Square
PDF
Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial
2026
·
Bakary Fofana
, Rella Zoleko-Manego
, et al.
·
The Lancet Infectious Diseases
Development, Validation and Application of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Activity and Inhibition of DPP-4
2022
·
Kees J Bronsema
, Wietske Lambert
, et al.
·
Bioanalysis
Population Pharmacokinetic Analysis of Fevipiprant in Healthy Subjects and Asthma Patients using a Tukey’s g-and-h Distribution
2021
·
Xinting Wang
, Christian Bartels
, et al.
·
Drug Research
PDF
Show more works
View as search
Works count:
17
Citation count:
224
H-index:
9
I10-index:
9
Year
Topic
Type